IP Verse

Ares Trading patent opposition analysis

Get complete Patent Opposition Report for Ares Trading

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Ares Trading

Explore patent oppositions filed by Ares Trading against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3021869	Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit Inhibitors	F HOFFMANN LA ROCHE	Apr 15, 2021
EP3144318	Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation	FERRING	Mar 25, 2021
EP3303632	Therapeutic And Diagnostic Methods For Cancer	F HOFFMANN LA ROCHE	Dec 4, 2020
EP3083686	Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And Taxanes	FHOFFMANN LA ROCHE	Jul 23, 2020
EP2542590	Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion Proteins	THE JOHNS HOPKINS UNIVERSITY	Feb 2, 2018

Latest patents of Ares Trading opposed by its competitors

Explore Ares Trading's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP2061803	Nov 16, 2022	Process For The Purification Of Fc-Containing Proteins	2
EP2827150	Aug 18, 2021	Imaging And Evaluating Embryos, Oocytes, And Stem Cells	1
EP3145488	Jul 22, 2020	Liquid Pharmaceutical Composition	3
EP3061013	Apr 22, 2020	Patient Care System Reporting Adherence To Treatment Regimen	1
EP2854790	Aug 29, 2018	Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media	1
EP3145487	Aug 22, 2018	Liquid Pharmaceutical Composition	1
EP3148510	Jun 27, 2018	Liquid Pharmaceutical Composition	2
EP2753634	Nov 1, 2017	Method For Preparing Active Form Of Tnfr-Fc Fusion Protein	1

Top competitors of Ares Trading

F HOFFMANN LA ROCHE

BIOGEN

FERRING